Infertility Research Studies
RESOLVE supports scientific and clinical infertility research studies that promotes knowledge, understanding, and well-being of people experiencing infertility and other family building challenges.
What Are My Options?
About Infertility Research Studies:
RESOLVE supports scientific and clinical research that promotes knowledge, understanding, and well-being of people experiencing infertility and other family building challenges. We list research studies open to individuals as an educational and information service only. The posting of research studies on this website is not an endorsement or recommendation of such studies.
To participate or learn more about a study, please click on the link associated with the study below.
To post a study, please complete this application. Researchers are not allowed to contact RESOLVE support groups or volunteers directly.
Research Studies:
The aim of this study is to understand the barriers and facilitators to perinatal care for people with uteruses. This study acknowledges that the intersectionalities of each participant's experience impacts their perinatal care and perspective of that care. These identities and experiences should be honored. Additionally, this study aims to consider perinatal in more inclusive terms by using language such as "person with uterus" rather than "women" or "mom." To learn more about this study, please contact Caitlin Senk at csenk@antioch.edu.
Study closes 03/31/2024.
Rhetoric professor Maria Novotny is collaborating with EMPOWER with Moxi to conduct an IRB-approved research to understand the preferred language to describe embryo donation from various stakeholders perspectives. We are seeking embryo donors/potential donors, embryo recipients/potential recipients, individuals conceived via embryo donation as well as fertility professionals to complete a brief survey. This 15-20 minute survey asks questions about your experiences with embryo donation and the language the embryo donor community uses when describing their family formation and genetic relationships. The end goal for this research is to develop a list of preferred terminology to best describe the familial relationships resulting from embryo donation. We hope that this information will improve the language used to describe families formed via embryo donation.
Contact novotnmt@uwm.edu for more information.
Study end date: 08/01/2024
To compare cumulative live birth rates from In Vitro Fertilization and Embryo Transfer (IVF-ET) cycles in women with endometriosis treated with a 60-day course of oral GnRH antagonist ORILISSA™ (elagolix) vs placebo prior to embryo transfer (ET). Must be between 18 years and 38 years old. The trial will last 50 months. Please contact Michele Frank RN, BSN from Yale School of Medicine by email at Michele.frank@yale.edu or call 203.785.6949.
Survey closes 10/1/2024
We’re looking for women ages 35–42 to participate in The PROGRESS Study.
The PROGRESS Study is an investigational study to determine if Progesterone-IBSA administered as an injection under the skin (subcutaneous) is safe and effective in supporting the implantation and early pregnancy following a frozen embryo transfer (FET).
About the Sponsor:
IBSA Group, the study Sponsor, is a multinational pharmaceutical company headquartered in Switzerland, operating in 90 countries around the globe (including US). IBSA is one of the major players worldwide in the field of Reproductive Medicine.
About the Study:
The hormone progesterone plays a vital role in early pregnancy. Our researchers are investigating an alternative way to administer progesterone with the aim to discover if subcutaneous (under-the-skin) injections are as safe and effective as the current approved medication Crinone®.
Crinone® is a progesterone gel that is administered vaginally and has been approved by the United States Food and Drug Administration, or FDA. The use of Progesterone-IBSA in this study is investigational. An investigational use is one that is not approved by FDA. However, Progesterone-IBSA is already approved and marketed in more than 30 countries worldwide.
The PROGRESS Trial is registered with clinicaltrials.gov, a website run by the National Institutes of Health (NIH) that provides information about clinical trials, and can be found at Clinical Trials NC NCT04549116.
If you’re interested in participating in this study, please contact one of the participating doctors nearest you by following the link below for more information: https://progressivfstudy.com/
Study closes 12/31/2024
Are you interested in sharing your story to help organizations better support individuals with infertility challenges?
Researchers at the University of Waterloo and the University of Georgia are looking for couples who are willing to share their story about how their infertility challenges impact them at work.
Participants will be asked to complete a short recruitment survey and then participate in a 60-minute interview. Each participant will be asked to partake in their own interview. To sign up, please visit: https://terry.qualtrics.com/jfe/form/SV_3F5Y4AYKNq1yF6K
All participants who partake in an interview will receive a $10 Amazon gift card. A bonus $15 Amazon gift card will be provided to each participant if their partner participates in a separate interview.
If you know of someone who would be interested in participating in this research, please feel free to forward the above link along to them.
An Institutional Review Board responsible for human subjects research at the University of Waterloo and the University of Georgia approved this research project, according to University policies designed to protect the rights and welfare of participants in research.
Please contact Janet Boekhorst, PhD (jaboekho@uwaterloo.ca) with any questions. Thank you!
Study ends 04/22/2024.
The direct medical costs of infertility, including the costs of medicines, labs, and visits, are significant. There are also many indirect costs of infertility such as money spent on testing supplies, educational materials, or supplements and time spent on travel, research, or care coordination. There has been limited research on the indirect costs of infertility and fertility care.
Researchers at the Mayo Clinic are evaluating the indirect costs of infertility and fertility care. In doing so, we hope to add a patient voice to the burden of fertility care and ultimately the patient experience. Participants will complete a 10-15 minute survey that asks about the money and time spent on the work of infertility. If you are interested in participating in the study, the survey can be found here: https://surveys.mayoclinic.org/jfe/form/SV_eVtTp4ZxL2ScLrg. If you know someone who may be interested in participating, please feel free to send them the survey link.
An Institutional Review Board responsible for human subjects research at the Mayo Clinic approved this study.
If you have any questions about this study, please email Danielle Aase, M.D. at aase.danielle@mayo.edu. Thank you!
Survey closes 06/01/2024.
Dr. Nitya Chawla (University of Minnesota) is currently recruiting for a research study focusing on the experiences of working women who have experienced a miscarriage (i.e., pregnancy loss prior to 20 weeks gestation) and are currently working full-time within the United States. By participating, you will be asked to complete a short in-take survey (approximately 5-10 minutes) and partake in a 60-minute interview via Zoom to share your experiences with the research team.
Your participation will assist in contributing to research that will provide important insight into how working women navigate the miscarriage experience as well as how organizations (and policy-makers more generally) can better support women during pregnancy loss. In exchange for your participation, you will receive a $25 gift card to Amazon or the opportunity to donate $25 to a non-profit organization of your choice (e.g., Vote Save America, Planned Parenthood, Black Lives Matter).
To participate in the study, please visit the following link to opt-in to participate, complete short survey measures to see if you are eligible, and schedule an interview date: https://bit.ly/miscarriageresearch
Study closes 4/1/24.